RxDoctor Payments DataLook up a doctor →

Jaspreet Singh, DO

Urology · New Windsor, NYNPI 1598859217

Payments from drug & device makers

$311,210in general payments, 2019–2025

Across 860 payments — averaging $361.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$202K
  • Coloplast$94K
  • Janssen Research & Development, LLC$4K
  • Medtronic$2K
  • Antares Pharma, Inc.$1K
  • Astellas Pharma US Inc$949
  • plus $8K from 54 others
$6,600in research payments, 2019–2025

Across 4 payments — averaging $1650.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Coloplast$7K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific280$201,673
Coloplast94$94,156
Janssen Research & Development, LLC4$3,679
Medtronic(3 entities)38$1,502
Antares Pharma, Inc.95$1,197
Astellas Pharma US Inc27$949
Neotract Inc.25$856
Teleflex LLC21$758
AbbVie(2 entities)27$532
Johnson & Johnson20$460
Bayer20$361
Urogen Pharma, Inc.13$350
Sumitomo Pharma America, Inc.12$345
Axonics, Inc.10$316
Pfizer16$256
Ferring Pharmaceuticals Inc.20$242
Rigicon,inc.3$213
Cardiovascular Systems Inc.1$192
Endo Pharmaceuticals Inc.10$189
Bard Access Systems, Inc.1$176
Myriad Genetic Laboratories, Inc.11$170
Alnylam Pharmaceuticals Inc.6$143
Progenics Pharmaceuticals, Inc.6$129
Novo Nordisk1$125
Organogenesis Inc.1$119
Endo USA, Inc.5$115
Takeda Pharmaceuticals U.S.A., Inc.5$115
Aimmune Therapeutics, Inc.5$105
Lilly USA, LLC5$99
AstraZeneca5$97
Urovant Sciences Inc5$95
Cook Medical LLC2$93
Procept Biorobotics Corporation3$90
Telix Pharmaceuticals5$89
Amgen4$84
Halozyme Inc5$79
180 Medical, Inc.3$71
Therapeuticsmd, Inc.4$66
Olympus Corporation Of The Americas1$65
Phathom Pharmaceuticals, Inc.3$59
Braintree Laboratories, Inc.2$53
QOL Medical, LLC2$52
Ardelyx, Inc.2$52
Verity Pharmaceuticals Inc.3$51
C. R. Bard, Inc. & Subsidiaries2$49
Tolmar, Inc.2$46
Intercept Pharmaceuticals, Inc.2$43
Hollister Incorporated2$42
ABC Home Medical Supply, Inc.2$41
Acerus Pharmaceuticals Corporation2$41
UCB, Inc.2$38
Palette Life Sciences, Inc.1$33
Kerecis Limited2$30
Myovant Sciences Inc.1$30
Merck1$29
KARL Storz Endoscopy-america1$25
Celltrion USA Inc.1$22
Olympus America Inc.1$19
Davol Inc.1$19
Tempus AI, Inc1$18

How this compares

$311,210 in reported general payments places this provider in the 95th percentile of 952 urology providers in New York.

See all urology providers in New York →

Medicare billing

Part B allowed, 2024
$655,942
Medicare patients
728
Services billed
11,593

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in New Windsor

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →